# Shilpa Medicare Limited – FDA Inspection, Feb 13, 2019

Source: https://www.keypedia.com/records/fda_inspections/shilpa-medicare-limited/a762f156-536e-49db-b3a7-d36e461a84f6
Source feed: FDA_Inspections

> FDA inspection 1079090 of Shilpa Medicare Limited, February 13, 2019. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1079090
- Company Name: Shilpa Medicare Limited
- Inspection Date: 2019-02-13
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/marcus-f-yambot/a2266014-ae7e-4d64-aeba-a8cfb873f100)

Company: https://www.keypedia.com/companies/shilpa-medicare-limited/557b8f74-b6b5-4c6e-980a-f229e76b35a0

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c